Press Release

Myomo to Present at The MicroCap Conference

Cambridge, MA., September 18, 2018/ ACCESSWIRE – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will be presenting at The MicroCap Conference on Monday, October 1st at 11:00 AM EDT, Track…

Read More

Myomo Announces Continued Momentum Across Europe

CAMBRIDGE, Mass. September 12, 2018 Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company, today announced continued momentum across Europe with the appointment of John Frijters as Business Development Manager for EU, a distributor agreement with Bandagist Jan Nielsen to deliver MyoPro to patients across Denmark and the first screening day in the…

Read More

Myomo Announces Second Quarter 2018 Financial Results

CAMBRIDGE, Mass., August 7, 2018 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today reports its financial results for the second quarter ended June 30, 2018. Read more.

Read More

Myomo to Report Second Quarter 2018 Results on August 7, 2018

CAMBRIDGE, Mass., July 31, 2018 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company, today announced that it will release its financial results for the second quarter 2018 on Tuesday, August 7, 2018, after the US markets close. Read more.

Read More

Myomo Appoints Micah Mitchell as Chief Commercial Officer

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company, announced today that Micah Mitchell is joining the company as chief commercial officer (CCO), a newly created executive role. The addition of a CCO reflects Myomo’s transition from a controlled introduction of its proprietary MyoPro product line to expansion of…

Read More

Research Team Presents Promising Preliminary Results from TBI Study Using Myomo’s MyoPro

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Researchers from the Northwestern University Prosthetics-Orthotics Center (NUPOC) and the Cleveland VA Medical Center have presented promising preliminary case reports from a clinical trial that evaluates the effects of the MyoPro myoelectric arm orthosis (powered brace) from Myomo on traumatic brain injury (TBI) patients at the Cleveland VA Medical Center. Read more.

Read More

Myomo Brings MyoPro to Adolescent Patients

CAMBRIDGE, Mass., June, 6, 2018 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company, today announced that its MyoPro myoelectric arm orthosis (powered brace) is now available to adolescent patients with paralyzed or weakened arms. MyoPro is the only lightweight wearable device on the market that can help restore…

Read More

Myomo Announces MyoPro Availability in 16 New U.S. Locations

CAMBRIDGE, Mass., May 24, 2018 – Myomo®, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced agreements with leading orthotics and prosthetics practices to bring MyoPro® availability to 16 new U.S. locations. Read more.

Read More

Myomo® Application for Medicare Codes Receives Favorable Preliminary Decision

CAMBRIDGE, Mass., May 14, 2018 – Myomo, Inc. (NYSE American: MYO) (“Myomo,” or the “Company”), a wearable medical robotics company, announces that the Centers for Medicare & Medicaid Services (“CMS”) has published a favorable preliminary decision regarding the Company’s application for Healthcare Common Procedure Coding System (HCPCS) “L” codes. Myomo had filed its application in December…

Read More

Myomo, Inc. Issues May 2018 Shareholder Letter

CAMBRIDGE, Mass., May 10, 2018 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today issued a letter to shareholders to give an update on first quarter 2018 and ongoing MyoPro® commercial activities. Read more.

Read More